Sanofi

A global integrated healthcare leader discovers, develops and distributes therapeutic solutions

Founded 1973 France

France 93305 employees IPO Total: $8.67B

General Information

Company Name Sanofi

Founded Year 1973

Location

France

Employees 93305

Funding Stage IPO

Business Model B2B, B2C, B2G

Revenue Model Product Sales, Licensing, Service Fee

Offices as of Sep 2026

Paris, France Karachi, Pakistan Singapore, Singapore Montevideo, Uruguay Swiftwater, United States Rio de Janeiro, Brazil Panama City, Panama Taguig City, Philippines San Isidro, Peru Sao Paulo, Brazil Berlin, Germany

Social

BounceWatch is an independent company data service, not affiliated with Sanofi. To contact Sanofi, visit sanofi.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sanofi compare?

A PDF of Sanofi and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sanofi soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Oct 01, 2026

Sanofi announced an expansion of its global alliance with Regeneron to add multiple next-generation, long-acting antibodies to their joint immunology portfolio.

Get alerts when Sanofi shows new signals

About Sanofi

Sanofi, founded in 1973, is a global integrated healthcare leader headquartered in France. As an R&D driven, AI-powered biopharma company, it boasts a noteworthy focus on improving lives through therapeutic solutions.

The company leverages its deep expertise in the immune system to develop medicines and vaccines, addressing significant healthcare, environmental, and societal challenges. This focus positions Sanofi as a potential industry frontrunner with an innovative pipeline that could positively impact millions globally.

Sanofi recently secured a substantial $3.00 billion Post IPO Debt investment, indicating strong financial backing and confidence from the investment community. Investors eyeing opportunities in the integrated healthcare sector might find Sanofi a compelling option, given its strategic market positioning and ambitious growth trajectory.

Business keywords: Integrated Healthcare, R&D Driven, AI-Powered Biopharma, Immune System Medicines, Therapeutic Solutions, Innovative Pipeline, Vaccines, Rare Diseases, Rare Blood Disorders, Neurology, Immunology, Oncology, Diabetes, Cardiovascular Diseases, Consumer Healthcare

Services & Products

Research & Development of Medicines and Vaccines

Clinical Trials Management

Digital Health Solutions

Manufacturing and Supply of Pharmaceuticals

Investor Relations and Business Development

Target Customers

Patients with Rare Diseases Healthcare Systems Medical Researchers Healthcare Providers Investors

Funding Rounds & Investors (10)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Post-IPO Debt	$3.00B	-		01 Oct 2025
Post-IPO Debt	€1.50B	-		01 Jun 2025
Post-IPO Debt	€1.50B	4	Deutsche Bank, JPMorgan +2	01 Mar 2025
Post-IPO Equity	$329.00M	1	Blackstone	01 Mar 2022
Grant	$2.00B	1	HHS Administration for Strategic Preparedness and Response	01 Jul 2020
Grant	$30.80M	1	HHS Administration for Strategic Preparedness and Response	01 Apr 2020
Post-IPO Equity	$310.00M	1	Evotec	01 Dec 2014
IPO	Undisclosed	-		01 Jul 2002
Merger	Undisclosed	1	Synthélabo	01 May 1999
Corporate Spinout	Undisclosed	1	Elf	01 Feb 1973

Latest News

View All

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants

Cnbc Nov 23, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Cnbc Nov 23, 2025

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

Cnbc Nov 23, 2025

IA : Anthropic ouvre un bureau à Paris

Lesechos.fr Nov 07, 2025

Sanofi, Blueprint Medicines'ı 9,1 milyar dolara satın almaya hazırlanıyor

Webrazzi Jun 02, 2025

JPM25, Day 1: GSK's billion-dollar bet, Bayer's trial first, Lilly buys Scorpion, and more

Fiercebiotech.com Jan 13, 2025

Sanofi Alternatives & Competitors

View All Alternatives

Sanofi vs

Flare Therapeutics United States

Trailblazing the path to drugging transcription factors to discover precision medicines for cancer &...

Series B

62 employees

Biopharma, Biotechnology

Sanofi vs

Novartis Switzerland

Reimagining medicine by transforming cancer

IPO

86998 employees

Biotechnology, Pharmaceutical

Sanofi vs

GSK United Kingdom

Science-led global healthcare co with a special purpose: to help people to do more, feel better, liv...

IPO

91965 employees

Biotechnology, Health Care

View all alternatives

FAQ About Sanofi

A global integrated healthcare leader discovers, develops and distributes therapeutic solutions

Sanofi was founded in 1973.

Sanofi is headquartered in France. As of Sep 2026, it also has offices in Paris, France, Karachi, Pakistan, Singapore, Singapore, Montevideo, Uruguay and Swiftwater, United States.

Sanofi has a B2B, B2C and B2G business model. Its revenue comes from Product Sales, Licensing and Service Fee.

Sanofi has approximately 93305 employees.

Sanofi has completed 10 funding rounds, raising a total of $8.67B. The latest funding stage is IPO.

Sanofi offers: Research & Development of Medicines and Vaccines, Clinical Trials Management, Digital Health Solutions, Manufacturing and Supply of Pharmaceuticals, Investor Relations and Business Development.

Top alternatives and competitors to Sanofi include Flare Therapeutics, Novartis, GSK, Incyte, Regor Therapeutics Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Sanofi and Flare Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sanofi, https://bouncewatch.com/company/sanofi, updated 2 September 2026. When citing, please name BounceWatch and link this page.

Sanofi

General Information

Discover More

What changed at Sanofi recently?

About Sanofi

Services & Products

Target Customers

Funding Rounds & Investors (10)

Latest News

Sanofi Alternatives & Competitors

FAQ About Sanofi